Docusate
MedicationColace, Correctol, Docusate, Surfak, Soflax
Stool softener laxative
Research strength: 2 / 5
MotherToBaby says docusate used as directed is unlikely to raise the chance of birth defects above background, but it gives no trimester-specific estimate. MotherToBaby says miscarriage studies have not been done. The NHS says docusate is occasionally used and reports no evidence of harm, while other laxatives are usually tried first because more pregnancy information is available. The US over-the-counter label says to ask a health professional before use. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- MotherToBaby: Docusate Sodium fact sheetTeratology service
- NHS: Pregnancy, breastfeeding and fertility while taking or using docusateUK government
- DailyMed: Equate Stool Softener Laxative docusate sodium softgel labelDrug company label
Research strength: 2 / 5
MotherToBaby says recommended-dose use is unlikely to cause problems such as preterm delivery or low birth weight, but it gives no trimester-specific results. A Cochrane review found no pregnancy trial data for stool-softener comparisons. The NHS says other laxatives are usually tried first because more pregnancy information is available. The US over-the-counter label says to ask a health professional before use. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- MotherToBaby: Docusate Sodium fact sheetTeratology service
- Cochrane: Interventions for treating constipation in pregnancyUS government
- NHS: Pregnancy, breastfeeding and fertility while taking or using docusateUK government
- DailyMed: Equate Stool Softener Laxative docusate sodium softgel labelDrug company label
Research strength: 2 / 5
MotherToBaby says recommended-dose use is unlikely to cause problems such as preterm delivery or low birth weight. Its sheet gives no third-trimester estimate and says no problems have been reported with recommended amounts. The NHS says docusate is occasionally used in pregnancy and reports no evidence of harm. The US over-the-counter label says to ask a health professional before use. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- MotherToBaby: Docusate Sodium fact sheetTeratology service
- NHS: Pregnancy, breastfeeding and fertility while taking or using docusateUK government
- DailyMed: Equate Stool Softener Laxative docusate sodium softgel labelDrug company label
Docusate — Breastfeeding
Research strength: 2 / 5
According to LactMed, docusate is minimally absorbed and unlikely to reach breast milk, but direct milk and infant levels have not been published. NHS SPS says docusate can be used during breastfeeding and specific infant monitoring is usually not needed. MotherToBaby says breastfeeding use has not been studied. The US over-the-counter label says to ask a health professional before use while breastfeeding. Ask your provider about your situation.
Last reviewed: 2026-10-16
Sources
- LactMed: DocusateUS government
- MotherToBaby: Docusate Sodium fact sheetTeratology service
- NHS Specialist Pharmacy Service: Using laxatives during breastfeedingUK government
- DailyMed: Equate Stool Softener Laxative docusate sodium softgel labelDrug company label
- Greenhalf and Leonard, Laxatives in the treatment of constipation in pregnant and breast-feeding mothersUS government
Pregnancy
MotherToBaby's January 2025 sheet says use as directed is unlikely to increase the chance of birth defects above background, and recommended doses are unlikely to cause preterm delivery or low birth weight. It gives no trimester-specific estimates. The sheet says miscarriage and future behavior or learning have not been studied. Aselton et al. (1985) examined first-trimester drug use among 6,509 mothers; the PubMed abstract reports no strong associations between commonly used drugs and certain congenital disorders, but gives no docusate-specific outcome. The DailyMed label gives a general precaution to ask a health professional before use.
Breastfeeding
LactMed's November 2024 revision says docusate is minimally absorbed and unlikely to be found in maternal serum or breast milk, but relevant published milk and infant level information was not found. LactMed cites a 1973 trial of docusate used with danthron, rather than docusate alone. MotherToBaby says breastfeeding use has not been studied. NHS SPS says docusate can be used during breastfeeding based on low oral bioavailability and says specific infant monitoring is usually not needed. The DailyMed label says to ask a health professional before use when pregnant or breast-feeding.
Docusate is a stool softener laxative. The cited Equate DailyMed label contains docusate sodium 100 mg in each softgel. That label is specific to one product; inactive ingredients and dosage forms can differ by brand. MotherToBaby lists Colace, Correctol, Docusate, Surfak, and Soflax as brand names.
What was tested
Pregnancy evidence includes older observational reports, with no trimester-specific risk estimates in the MotherToBaby sheet. Aselton et al. examined a broad range of first-trimester medicines, but its abstract does not report a docusate-specific result. The Cochrane review found no pregnancy trial data for stool-softener comparisons. Breastfeeding evidence includes low-absorption reasoning and a 1973 trial of docusate combined with danthron, not docusate alone; LactMed reports no published human milk or infant levels.
How pregnancy evidence and product-label precautions should be described
- Source A says
- MotherToBaby says use as directed is unlikely to raise birth defect chance above background. The NHS says occasional use has no evidence of harm, although it usually tries other laxatives first because more pregnancy information is available. (MotherToBaby: Docusate Sodium fact sheet, NHS: Pregnancy, breastfeeding and fertility while taking or using docusate)
- Source B says
- The US over-the-counter label says to ask a health professional before use. (DailyMed: Equate Stool Softener Laxative docusate sodium softgel label)
- Why they differ
- MotherToBaby and the NHS describe the available observations and absence of a known signal. The product label takes a cautious position and directs users to consult a health professional. None of these sources gives a trimester-specific risk estimate.
- Other sources
- The Cochrane review found no data for pregnancy trial comparisons involving stool softeners. (Rungsiprakarn et al., Cochrane review: Interventions for treating constipation in pregnancy)
- What the evidence shows overall
- The available sources do not establish a pregnancy risk with use as directed, but human evidence is limited. Keep the compatible rating under R1 and show the product-label consultation advice and evidence gap rather than implying that all sources agree.
Docusate during breastfeeding and possible infant effects
- Source A says
- LactMed says docusate is minimally absorbed and unlikely to be found in milk. NHS SPS says it can be used during breastfeeding and specific infant monitoring is usually not needed. (LactMed: Docusate, NHS Specialist Pharmacy Service: Using laxatives during breastfeeding)
- Source B says
- The US over-the-counter label says to ask a health professional before use while breast-feeding. (DailyMed: Equate Stool Softener Laxative docusate sodium softgel label)
- Why they differ
- LactMed and NHS SPS infer low exposure from low oral absorption. The DailyMed label does not make a milk-level claim; it advises consultation before breastfeeding use.
- Other sources
- MotherToBaby says direct breastfeeding use has not been studied. (MotherToBaby: Docusate Sodium fact sheet)
- What the evidence shows overall
- Direct human milk and infant data are sparse. Guidance remains appropriate because clinical sources differ and direct evidence is limited.
- The NHS says fiber, fluids, and gentle activity can be tried before medicine. If those measures do not help, a doctor or midwife may recommend lactulose or Fybogel. (NHS)
- NHS SPS says lifestyle measures are tried first and that a laxative, if needed, is used at the lowest dose for the shortest time possible. (NHS Specialist Pharmacy Service)
- The US over-the-counter label says to ask a health professional before use during pregnancy or breastfeeding. (DailyMed Equate label)
General research, not specific to pregnancy.
The cited Equate label describes docusate sodium 100 mg softgels for occasional constipation and lists general limits for use.
- The label says the product is for relief of occasional constipation and generally produces a bowel movement in 12 to 72 hours. (DailyMed: Equate Stool Softener Laxative docusate sodium softgel label)
- The label says not to use it with mineral oil unless directed by a doctor. It says to stop use and ask a doctor for rectal bleeding, no bowel movement after use, or a need to use a laxative for more than one week. (DailyMed: Equate Stool Softener Laxative docusate sodium softgel label)
- MotherToBaby: Docusate Sodium fact sheetTeratology serviceSecondaryPage dated 2025-01-01
- LactMed: DocusateUS governmentSecondaryPage dated 2024-11-15
- DailyMed: Equate Stool Softener Laxative docusate sodium softgel labelDrug company labelTertiaryPage dated 2026-09-23
- NHS: Pregnancy, breastfeeding and fertility while taking or using docusateUK governmentSecondaryPage dated 2024-05-10Independent check
- NHS Specialist Pharmacy Service: Using laxatives during breastfeedingUK governmentSecondaryPage dated 2023-11-10Independent check
- Rungsiprakarn et al., Cochrane review: Interventions for treating constipation in pregnancyUS governmentPrimaryIndependent check
- Aselton et al., First-trimester drug use and congenital disordersUS governmentPrimary
- Greenhalf and Leonard, Laxatives in the treatment of constipation in pregnant and breast-feeding mothersUS governmentPrimary
Last reviewed 2026-10-16
Independent check 2026-10-16
Not yet clinician-reviewed
Ask your provider about your situation.
Similar medications
- Glycerin